IPG Investment Advisors’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.3K Hold
17,169
﹤0.01% 268
2026
Q1
$22.8K Hold
17,169
﹤0.01% 242
2025
Q4
$19.1K Buy
+17,169
New +$30.8K ﹤0.01% 222
2025
Q1
Sell
-17,169
Closed -$35.7K 177
2024
Q4
$35.7K Hold
17,169
0.01% 170
2024
Q3
$51K Hold
17,169
0.01% 169
2024
Q2
$53.7K Hold
17,169
0.01% 167
2024
Q1
$89.8K Sell
17,169
-1
-0% -$4 0.02% 158
2023
Q4
$42.5K Hold
17,170
0.01% 186
2023
Q3
$38.1K Buy
17,170
+8,493
+98% +$30.5K 0.01% 155
2023
Q2
$46.2K Hold
8,677
0.01% 165
2023
Q1
$53.8K Buy
8,677
+4,000
+86% +$32.2K 0.01% 156
2022
Q4
$60.3K Hold
4,677
0.02% 129
2022
Q3
$108K Buy
4,677
+1,137
+32% +$34.5K 0.03% 126
2022
Q2
$120K Buy
3,540
+2,286
+182% +$186K 0.03% 139
2022
Q1
$109K Buy
+1,254
New +$75.1K 0.02% 156

Other funds holding CELU

IPG Investment Advisors's CELU Position: Q2 2026 in Review

IPG Investment Advisors held its Celularity (CELU) position steady in Q2 2026 at 17,169 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #268.

IPG Investment Advisors first reported a position in CELU in Q1 2022 and has held it in 15 quarters since. The position peaked at $120K in Q2 2022. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

  • IPG Investment Advisors held 17,169 shares of Celularity worth $10.3K as of Q2 2026.
  • IPG Investment Advisors left its Celularity share count unchanged in Q2 2026.
  • Celularity made up ﹤0.01% of IPG Investment Advisors's portfolio in Q2 2026, its #268 holding.
  • IPG Investment Advisors first reported a position in Celularity in Q1 2022 and has held it in 15 quarters since.
  • IPG Investment Advisors's Celularity position peaked at $120K in Q2 2022.
  • 39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on IPG Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.